CLINICAL_TRIALS
trial_result
· 2017-05-31
Clinical Trial Update: Changes in Bone Turnover With Increased Incretin Hormone Exposure [Phase 4]
Summary
Phase 4 clinical trial update examining how increased incretin hormone exposure affects bone turnover in individuals with type 2 diabetes. The study was termina…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of Alabama at Birmingham | Conditions: Type 2 Diabetes Mellitus | Phase 4 | Status: TERMINATED | Results posted: 2017-05-31